Hot Stocks to Watch: Hydrogen Momentum, Entertainment Expansion, and Energy Disruption

July 9, 2025

DENVER, Colo., Jul 09, 2025 (247marketnews.com)- Plug Power (NASDAQ:PLUG), a global leader in hydrogen fuel cell solutions, announced a multi-year enhanced supply agreement with a major U.S.-based industrial gas company—an existing partner—extending their relationship through 2030. This deal not only secures a reliable hydrogen supply for Plug’s growing applications across mobility and stationary power, but also lowers its cost structure and improves cash flows, two key investor concerns in recent quarters. The strategic extension underscores Plug’s role as a cornerstone player in the U.S. hydrogen economy, amid rising demand for clean energy infrastructure and government incentives tied to the Inflation Reduction Act.

Venu (NYSE:VENU) continues to scale rapidly with the launch of its new Growth and Strategy division, now led by former Live Nation SVP Terri Liebler. This strategic hire aligns with Venu’s aggressive two-facilities-per-quarter rollout plan and a goal of achieving $200 million in 2025 luxury suite sales. The company’s fan-first, asset-backed ownership model is gaining traction as Venu expands via public-private partnerships and real estate-driven growth.

Analysts are taking notice:

  • Northland Capital upgraded VENU to “Outperform” with a $15 price target, citing strong execution.
  • ThinkEquity echoed the bullish stance with a “Buy” rating and matching $15 target, highlighting confidence in the company’s innovative footprint in the live entertainment and venue infrastructure sector.

With a scalable business model and growing institutional support, Venu is fast becoming one of the most compelling small-cap growth stories of 2025.

Shares of AES (NYSE:AES) are trending higher after Barron’s reported the utility and renewable energy company is “exploring its options, including a possible sale.”

Bloom Energy (NYSE:BE) is making waves as one of the top dollar volume gainers today. The company designs and manufactures solid-oxide fuel cell systems, offering reliable on-site power solutions for commercial and industrial clients.

Basel Medical (NASDAQ:BMGL), a recent entrant to U.S. markets, is positioning itself as a next-generation medical diagnostics company, with a focus on advanced testing technologies for early disease detection, including cancer and metabolic disorders.

Calidi Biotherapeutics (NYSEAMERICAN:CLDI) continues to attract attention for its work in oncolytic virotherapy, an emerging frontier in immuno-oncology. The company is advancing its NeuroNova platform, which combines stem cell delivery with tumor-selective viruses designed to target and destroy cancer cells.

For additional 247marketnews.com Venu disclosure go to https://247marketnews.com/venu-disclosure/.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (BMGL, PLUG, VENU, AES, BE, CLDI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.